464 related articles for article (PubMed ID: 15163258)
1. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP
J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
3. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia.
Copolov DL; Link CG; Kowalcyk B
Psychol Med; 2000 Jan; 30(1):95-105. PubMed ID: 10722180
[TBL] [Abstract][Full Text] [Related]
4. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
Arvanitis LA; Miller BG
Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
[TBL] [Abstract][Full Text] [Related]
5. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group.
Emsley RA; Raniwalla J; Bailey PJ; Jones AM
Int Clin Psychopharmacol; 2000 May; 15(3):121-31. PubMed ID: 10870870
[TBL] [Abstract][Full Text] [Related]
7. Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder.
Glick ID; Marder SR
J Clin Psychiatry; 2005 May; 66(5):638-41. PubMed ID: 15889952
[TBL] [Abstract][Full Text] [Related]
8. [Utility of quetiapine in tardive dyskinesia].
Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
[TBL] [Abstract][Full Text] [Related]
9. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia with quetiapine.
Ghelber D; Belmaker RH
Am J Psychiatry; 1999 May; 156(5):796-7. PubMed ID: 10327920
[No Abstract] [Full Text] [Related]
11. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
Kane JM; Carson WH; Saha AR; McQuade RD; Ingenito GG; Zimbroff DL; Ali MW
J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115
[TBL] [Abstract][Full Text] [Related]
13. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Correll CU; Leucht S; Kane JM
Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia in a patient treated with quetiapine.
Rizos E; Douzenis A; Gournellis R; Christodoulou C; Lykouras LP
World J Biol Psychiatry; 2009; 10(1):54-7. PubMed ID: 19673087
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia.
Alptekin K; Kivircik BB
Int Clin Psychopharmacol; 2002 Sep; 17(5):263-4. PubMed ID: 12177588
[TBL] [Abstract][Full Text] [Related]
17. An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.
Goff DC; Posever T; Herz L; Simmons J; Kletti N; Lapierre K; Wilner KD; Law CG; Ko GN
J Clin Psychopharmacol; 1998 Aug; 18(4):296-304. PubMed ID: 9690695
[TBL] [Abstract][Full Text] [Related]
18. Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.
Zhong KX; Sweitzer DE; Hamer RM; Lieberman JA
J Clin Psychiatry; 2006 Jul; 67(7):1093-103. PubMed ID: 16889453
[TBL] [Abstract][Full Text] [Related]
19. Tardive dyskinesia rates with atypical antipsychotics in older adults.
Jeste DV
J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia.
Chan HY; Chiang SC; Chang CJ; Gau SS; Chen JJ; Chen CH; Hwu HG; Lai MS
J Clin Psychiatry; 2010 Sep; 71(9):1226-33. PubMed ID: 20441726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
